4//SEC Filing
SHARP PHILLIP A 4
Accession 0001735276-24-000022
CIK 0001178670other
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 4:12 PM ET
Size
19.1 KB
Accession
0001735276-24-000022
Insider Transaction Report
Form 4
SHARP PHILIP A
Director
Transactions
- Sale
Common Stock
2024-02-29$154.07/sh−101$15,561→ 516 total - Exercise/Conversion
Stock Option (right to buy)
2024-02-29−30,000→ 0 totalExercise: $59.25From: 2015-06-05Exp: 2024-06-04→ Common Stock (30,000 underlying) - Sale
Common Stock
2024-02-29$156.54/sh−516$80,775→ 0 total - Exercise/Conversion
Common Stock
2024-02-29$59.25/sh+30,000$1,777,500→ 30,000 total - Sale
Common Stock
2024-02-29$153.62/sh−1,906$292,800→ 617 total - Sale
Common Stock
2024-02-29$150.60/sh−13,005$1,958,553→ 16,995 total - Sale
Common Stock
2024-02-29$151.43/sh−13,557$2,052,937→ 3,438 total - Sale
Common Stock
2024-02-29$152.40/sh−915$139,446→ 2,523 total
Holdings
- 266,899(indirect: By Trust)
Common Stock
Footnotes (8)
- [F1]The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. The 30,000 options exercised and sold by the reporting person were due to expire on June 4, 2024.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $150.00 to $151.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $151.01 to $151.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $152.02 to $152.91. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $153.04 to $154.03. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F6]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $154.06 to $154.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F7]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $156.15 to $156.98. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F8]Includes shares held by the Phillip A. Sharp Revocable Trust, of which the reporting person and his spouse are co-trustees. Also includes shares held in trust for the benefit of the reporting persons children, of which the reporting persons children and spouse are the trustees.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001226295
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 4:12 PM ET
- Size
- 19.1 KB